NASDAQ:CTMX

Cytomx Therapeutics Stock Predictions

etoro logo Buy CTMX
*Your capital is at risk
$3.16
-0.290 (-8.41%)
At Close: Jun 02, 2026
Currently predicting for Thu, 4 Jun 2026

CTMX Prediction Chart

CTMX Predictions History

Latest community submissions for CTMX.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 18, 2025 $3.64 +2.52% $3.66 V 99.43% 4
Nov 18, 2025 Bullish $3.66 V 1
Nov 13, 2025 $4.09 -3.28% $3.86 V 94.01% 1
Nov 13, 2025 $4.14 -2.05% $3.86 V 92.66% 1
Nov 13, 2025 $5.19 +26.59% $3.86 X 65.54% 0
Nov 5, 2025 $3.98 -2.72% $4.21 X 94.51% 0
Nov 5, 2025 $4.02 -1.70% $4.21 X 95.50% 0
Nov 5, 2025 Bullish $4.21 V 1
Sep 29, 2025 $2.82 -2.77% $3.23 X 87.30% 0
Sep 29, 2025 $2.85 -1.73% $3.23 X 88.23% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CTMX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CYTOMX THERAPEUTICS
CytomX Therapeutics
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE